Core ScientificCORZ
CORZ logo
Fair Value
US$35.86
Share price29 Jul
US$22.8136.4% undervalued intrinsic discount
Loading
1Y62.00%
7D9.95%

CORZ: Power Portfolio And AI Demand Will Unlock Substantial Upside

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
23 Apr 25
Updated
29 Jul 26
Views
919
Not Invested

Last Update 29 Jul 26

Fair value Increased 7.49%

CORZ: Long Dated AI Power Leases Will Drive Future Returns

Analysts have raised their fair value estimate for Core Scientific from $33.36 to $35.86, citing higher price targets and expanded AI and high performance compute contracts. The revised estimate also reflects updated assumptions for the discount rate, revenue growth, profit margins, and future P/E levels.

Analyst Commentary

Recent research on Core Scientific highlights a split view. Bullish analysts point to large AI and high performance compute contracts and growing contracted power capacity. More cautious voices focus on how much of that potential may already be reflected in the current Core Scientific share price and on execution risk around future leases.

Bullish Takeaways

  • Bullish analysts see the long term high performance compute colocation agreement tied to AMD as a key support for growth, with 15 years of contracted revenue across US$14b of commitments and roughly 530 MW of IT capacity.
  • The AMD related deals and other hyperscale contracts take Core Scientific to roughly 1.1 GW of contracted billable capacity and over 1 GW of leased high performance compute capacity, which bullish analysts frame as support for their higher valuation work.
  • Several bullish analysts link rising price targets to Core Scientific expanding its approved and reserved power capacity, including references to 1.2 GW of approved power this year and nearly 1.9 GW of additional reserved capacity that could support incremental contracts.
  • Some bullish analysts argue that Core Scientific is building a scalable AI infrastructure platform, with its pivot away from bitcoin mining and existing lease agreements used as key inputs into higher target prices and updated valuation methodologies.

Bearish Takeaways

  • Bearish analysts argue that Core Scientific already trades above their estimate of equity value on the existing lease portfolio and net debt, which leads them to more cautious price targets and ratings.
  • There is concern that a large portion of the expected business inflection around 2027 and 2028 is already reflected in the stock, especially after a share price move of 87% year to date and 124% over the past twelve months referenced in one report.
  • Some bearish analysts point to elevated execution risk, noting that new lease deals have taken longer to finalize than previously expected, which raises questions around how quickly Core Scientific can translate its power and site pipeline into contracted cash flows.
  • Cautious voices also highlight that the market may already be pricing in much of the capacity that can realistically be leased over the near to medium term, which could limit upside if contract momentum or economics differ from current expectations.

What’s in the News for Core Scientific

  • Core Scientific signed a 15 year AI infrastructure partnership with AMD that includes initial leases for 529 MW of data center capacity across Texas, Oklahoma, Alabama and Georgia, with AMD able to reserve up to 2.5 GW of capacity by 2028 and more than US$14b in projected base contracted revenue. Source: recent AMD partnership announcement.
  • The AMD agreement supports Core Scientific’s shift away from bitcoin mining toward AI infrastructure services, with leased power capacity at roughly 1.1 GW as of mid 2026 and potential contracted revenue cited at more than US$24b, while current billing for 437 MW was tied to about US$635m in annualized colocation GAAP revenue. Source: recent AMD partnership announcement.
  • Core Scientific reported Q2 2026 revenue of US$164.2m, which the company attributed mainly to the Colocation segment, and a net loss of US$1.16b or a loss of US$3.32 per share, alongside heavy investment in infrastructure to support AI and digital asset clients. Source: Alphastreet Q2 2026 results.
  • KBW downgraded Core Scientific to Market Perform from Outperform and cut its price target, citing higher execution risk as the company commits around US$2b to 2026 data center development and acquisitions before securing matching lease contracts, while construction of new data halls is moving ahead without signed customers. Source: KBW research.
  • Core Scientific outlined plans to scale its Muskogee, Oklahoma campus to about 1.5 GW of gross power, or about 1.0 GW of leasable power, supported by roughly 250 acres of land, and reported that its leased 70 MW building designed for the Nvidia GB300 platform is in final testing and commissioning for a targeted Q2 2026 customer delivery. Source: company expansion update.

Valuation Changes for Core Scientific

  • Fair Value has risen modestly, with the estimate moving from $33.36 to $35.86 per share.
  • Discount Rate has increased from 9.37% to 10.35%, which points to a higher required return in the updated model.
  • Revenue Growth has been marked down from 80.73% to 75.40%, indicating slightly more conservative top line expectations for Core Scientific.
  • Net Profit Margin has risen from 14.90% to 17.74%, reflecting a stronger assumed level of profitability in future periods.
  • Future P/E has been reduced from 50.06x to 42.74x, which implies a lower valuation multiple applied to Core Scientific in the latest work.
6 viewsusers have viewed this narrative update

Key Takeaways

  • Reallocating resources from Bitcoin mining to HPC infrastructure could drive future growth amid rising data center demands and diversified clientele.
  • Debt restructuring and 0% interest funding improve growth potential and operational efficiencies through strategic hires, enhancing financial stability and earnings.
  • Dependency on CoreWeave, shift in strategy, restructuring uncertainties, and execution delays pose risks to growth and profitability.

Catalysts

About Core Scientific
    Provides digital asset mining services in the United States.
What are the underlying business or industry changes driving this perspective?
  • Core Scientific secured a major HPC contract with CoreWeave, with a total revenue potential of $8.7 billion over a 12-year term, significantly boosting future revenue compared to their current levels.
  • The company is expanding HPC infrastructure capacity by reallocating resources from Bitcoin mining, adding new sites, and extending existing ones, expecting to drive future revenue growth as data center needs rise.
  • Core Scientific’s ability to diversify its customer base and reduce reliance on CoreWeave as a primary client could improve margins and provide more stable revenue streams in the long term.
  • The improved balance sheet following significant debt restructuring and raising $625 million through a convertible note offering at 0% interest rates positions the company to effectively fund future growth initiatives with lower interest costs, improving net margins.
  • Strategic hires of data center professionals enhance execution capabilities, likely leading to increased operational efficiencies, positively impacting earnings as the company grows its data center business.
Core Scientific Earnings and Revenue Growth

Core Scientific Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Core Scientific's revenue will grow by 75.4% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -370.8% today to 17.7% in 3 years time.
  • Analysts expect earnings to reach $421.6 million (and earnings per share of $1.03) by about July 2029, up from -$1.6 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $1.7 billion in earnings, and the most bearish expecting $-1.1 billion.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 42.8x on those 2029 earnings, up from -3.6x today. This future PE is greater than the current PE for the US Software industry at 29.3x.
  • Analysts expect the number of shares outstanding to grow by 5.22% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 10.35%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The shift from Bitcoin mining to HPC hosting and the resulting decline in digital asset hosted mining revenue, which was down significantly from $30 million to $6.5 million, could adversely impact overall revenue if the new strategy doesn't ramp up as expected.
  • The company faced a net loss of $265 million in the fourth quarter of 2024, an increase from the previous year's loss, raising concerns about its ability to reach profitability and improve net margins in the near term.
  • The dependency on a singular client, CoreWeave, for a significant portion of projected revenue introduces concentration risk. If CoreWeave's demand or business model shifts unfavorably, it could dramatically decrease Core Scientific's forecasted earnings.
  • With the recent Chapter 11 debt restructuring, there remains uncertainty about the company’s long-term financial health and its reliance on future capital expenditures, which could put strain on cash flow and negate earnings improvements.
  • The delayed rollout of planned HPC capacity expansions due to permitting and equipment issues could slow revenue growth and heighten execution risk, potentially impacting future earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $35.86 for Core Scientific based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $55.0, and the most bearish reporting a price target of just $25.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $2.4 billion, earnings will come to $421.6 million, and it would be trading on a PE ratio of 42.8x, assuming you use a discount rate of 10.3%.
  • Given the current share price of $18.12, the analyst price target of $35.86 is 49.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Core Scientific?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$35.86
vs US$22.8136.4% undervalued intrinsic discount
PastFuture-1b2b2019202120232025202620272029Revenue US$2.4bEarnings US$421.6m
75.4%
Revenue growth
17.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Core Scientific

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

High growth potential with low risk.

Market capUS$7.3b
PB-3.0x
Estimated Growth36.8%
Dividend YieldN/A
Full analysis

CEO & management

Adam Sullivan
CEO
2.2yrs
CEO Tenure

Provides infrastructure for high-density colocation services and digital asset mining in the United States.